Huangjia Ruangan Granule Inhibits Inflammation in a Rat Model with Liver Fibrosis by Regulating TNF/MAPK and NF-<i>κ</i>B Signaling Pathways

<div>The results of HJRG by HPLC. (a) The reference substance of paeoniflorin, notoginsenoside R1, and astragaloside A in HPLC. (b) The reference substance of gallic acid, puerarin, and tanshinone IIA in HPLC. (c) The HPLC analysis results of HJRG. (1) Paeoniflorin; (2) notoginsenoside R1; (3) astragaloside (A). (d) The HPLC analysis results of HJRG. (4) Gallic acid. (5) Puerarin. (6) Tanshinone IIA.</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Huangjia Ruangan Granule Inhibits Inflammation in a Rat Model with Liver Fibrosis by Regulating TNF/MAPK and NF-<i>κ</i>B Signaling Pathways 

Evidence-Based Complementary and Alternative Medicine

Huangjia Ruangan Granule Inhibits Inflammation in a Rat Model with Liver Fibrosis by Regulating TNF/MAPK and NF-κB Signaling Pathways

Figure 1